OPNT - Opiant Pharmaceuticals GAAP EPS of -$1.93 misses by $0.42 revenue of $0.2M misses by $3.48M
- Opiant Pharmaceuticals press release ( NASDAQ: OPNT ): Q3 GAAP EPS of -$1.93 misses by $0.42 .
- Revenue of $0.2M (-98.8% Y/Y) misses by $3.48M .
- As of September 30, 2022, Opiant had $35.4M in cash and cash equivalents.
For further details see:
Opiant Pharmaceuticals GAAP EPS of -$1.93 misses by $0.42, revenue of $0.2M misses by $3.48M